Skip to main content
. Author manuscript; available in PMC: 2010 Nov 22.
Published in final edited form as: Arch Phys Med Rehabil. 2008 Jun 13;89(7):1221–1229. doi: 10.1016/j.apmr.2008.01.013

Table 1. Clinical Characteristics of PD Subjects at Baseline.

Characteristics Zero Intensity Low Intensity High Intensity
Patients (n) 10 10 10
Sex (male/female) 8/2 5/5 6/4
Age (y) 63.1±11.5 61.5±9.8 64.0±14.5
Hoehn and Yahr stage 1.9±0.3 1.9±0.3 1.9±0.5
Duration of PD (mo) 17.7±13.3 8.8±7.9 14.7±9.9
MMSE score 29.6±0.7 29.3±0.8 28.9±1.1
Medications
 Levodopa (mg) 90.0±202.5 15.0±47.4 115.0±226.1
 Pramipexole (mg) 0.5±0.7 0.3±0.9 0.5±.1.0
 Ropinerole (mg) 0 0 1.6±5.1

 Amantadine 30.0±94.9 20.0±63.2 30.0±94.8
 Selegiline 0.5±1.6 1.0±3.2 1.0±2.1

NOTE. Values are mean ± SD.